TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations

Authors

Paarth B Dodhiawala, Washington University School of Medicine in St. Louis
Namrata Khurana, Washington University School of Medicine in St. Louis
Daoxiang Zhang, Washington University School of Medicine in St. Louis
Yi Cheng, Washington University School of Medicine in St. Louis
Lin Li, Washington University School of Medicine in St. Louis
Qing Wei, Washington University School of Medicine in St. Louis
Kuljeet Seehra, Washington University School of Medicine in St. Louis
Hongmei Jiang, Washington University School of Medicine in St. Louis
Patrick M Grierson, Washington University School of Medicine in St. Louis
Andrea Wang-Gillam, Washington University School of Medicine in St. Louis
Kian-Huat Lim, Washington University School of Medicine in St. Louis

Journal

The Journal of Clinical Investigation

Publication Date

2020

Volume

130

Issue

9

First Page

4771

Last Page

4790

Document Type

Open Access Publication

DOI

10.1172/JCI137660

Rights and Permissions

Dodhiawala PB, Khurana N, Zhang D, et al. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations. J Clin Invest. 2020;130(9):4771-4790. doi:10.1172/JCI137660.

Recommended Citation

Dodhiawala, Paarth B; Khurana, Namrata; Zhang, Daoxiang; Cheng, Yi; Li, Lin; Wei, Qing; Seehra, Kuljeet; Jiang, Hongmei; Grierson, Patrick M; Wang-Gillam, Andrea; and Lim, Kian-Huat, "TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations." The Journal of Clinical Investigation. 130, 9. 4771 - 4790. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9359